Immucor and Pirche announce multi-year partnership
October 04, 2022 08:04 ET
|
Immucor, Inc.
NORCROSS, Ga. and BERLIN, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics, and Pirche AG, the global leader in AI-powered molecular...
Global Organ Transplant Market Report 2022: Rising Need for Innovative Tissue Transplantation Products and Organ Transplantation to Treat Organ Failure Propelling Sector
September 06, 2022 05:23 ET
|
Research and Markets
Dublin, Sept. 06, 2022 (GLOBE NEWSWIRE) -- The "Global Organ Transplant Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering.A major element driving...
Surreal Photography Exhibit Brings Awareness
September 01, 2022 09:30 ET
|
Texas Organ Sharing Alliance
Austin, TX, Sept. 01, 2022 (GLOBE NEWSWIRE) -- AUSTIN, TX (September 1, 2022) – A Central Texas couple who create fine-art surreal photographs is collaborating with the Austin-Bergstrom...
Eledon Pharmaceuticals to Participate in Two Upcoming Investor Conferences
August 29, 2022 08:00 ET
|
Eledon Pharmaceuticals, Inc.
IRVINE, Calif., Aug. 29, 2022 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), today announced that senior management will participate in two upcoming investor...
The Worldwide Organ Transplant Diagnostics Industry is Expected to Reach $6 Billion by 2031
August 12, 2022 07:08 ET
|
Research and Markets
Dublin, Aug. 12, 2022 (GLOBE NEWSWIRE) -- The "Global Organ Transplant Diagnostics Market 2021-2031 by Offering, Transplant, Application, Technology, End User, and Region: Trend Forecast and Growth...
Eledon Pharmaceuticals Reports Second Quarter 2022 Operating and Financial Results
August 11, 2022 16:01 ET
|
Eledon Pharmaceuticals, Inc.
Received FDA clearance of IND application for Phase 2 trial evaluating tegoprubart for the prevention of rejection in kidney transplant recipients First patient dosed in Phase 1b trial evaluating...
Eledon Pharmaceuticals to Report Second Quarter 2022 Financial Results on Thursday, August 11, 2022
August 04, 2022 16:05 ET
|
Eledon Pharmaceuticals, Inc.
Management to host conference call and webcast at 4:30 pm ET IRVINE, Calif., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a patient-focused clinical...
Eledon Pharmaceuticals Receives FDA Clearance of IND Application to Evaluate Tegoprubart for the Prevention of Rejection in Kidney Transplant Recipients
August 01, 2022 05:00 ET
|
Eledon Pharmaceuticals, Inc.
IRVINE, Calif., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a patient-focused clinical stage biopharmaceutical company committed to the development of...
Eledon Pharmaceuticals Announces the First Patient Dosed in Phase 1b Trial Evaluating Tegoprubart in Kidney Transplantation
July 18, 2022 08:00 ET
|
Eledon Pharmaceuticals, Inc.
IRVINE, Calif., July 18, 2022 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a patient-focused clinical stage biopharmaceutical company committed to the development of...
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 10, 2022 16:05 ET
|
Eledon Pharmaceuticals, Inc.
IRVINE, Calif., June 10, 2022 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a patient-focused clinical stage biopharmaceutical company committed to the development of...